

Combination of Leber’s Hereditary Optic Neuropathy and Multiple Sclerosis
https://doi.org/10.30629/2658-7947-2025-30-4-38-43
Abstract
In this article we present a clinical case of a combination of Leber’s hereditary optic neuropathy (LHON) and multiple sclerosis (MS) in a 19-year-old female patient. Initially disease manifested with painless vision loss in the right eye. Two weeks later, the patient experienced visual impairment in the second eye. MRI of the brain and spinal cord revealed lesions typical for MS. Laboratory examination revealed CSF oligoclonal bands (type 2 synthesis). Despite undergoing pulse therapy with methylprednisolone and plasma exchange, no improvement in vision was observed. The course of optic neuropathy was atypical for MS, leading to a suspicion of LHON. Genetic testing identifi ed the mutation m.11778G > A in the MT-ND4 gene, confi rming the diagnosis. This case highlights the need for further investigation into the comorbidity of MS with LHON and the shared pathophysiological mechanisms underlying both diseases.
About the Authors
D. E. ProkhorovRussian Federation
Moscow, Russia
Sh. R. Nabiev
Russian Federation
Moscow, Russia
R. R. Zhetishev
Russian Federation
Moscow, Russia
I. S. Zhetisheva
Russian Federation
Nalchik, Russia
O. N. Voskresenskaya
Russian Federation
Moscow, Russia
References
1. Zemlyanushina S.M., Vashkulatova E.A., Zemlyanushin L.S., Sokolova A.A., Balagdashova G.T. Clinical case analysis: hereditary optical Leber’s neuropathy. Practical Medicine. 2019;17(7):170–172. (In Russ.). https://doi.org/10.32000/2072-1757-2019-7-170-172
2. Andreeva NA, Murakhovskaya YuK, Krylova TD, Tsygankova PG, Sheremet NL. Rare pathogenic nucleotide variants of mitochondrial DNA associated with Leber’s hereditary optic neuropathy. Russian Annals of Ophthalmology. 2023;139(6):166–174. (In Russ.). https://doi.org/10.17116/oftalma2023139061166
3. Eliseeva DD, Kalashnikova AK, Bryukhov VV, Andreeva NA, Zhorzholadze NV, Murakhovskaya YuK, Krilova TD, Tsygankova PG, Zakharova MN, Sheremet NL. Hereditary optic neuropathy associated with demyelinating diseases of the central nervous system. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2023;123(7 vyp 2):122–132. (In Russ.). https://doi.org/10.17116/jnevro2023123072122
4. Yu-Wai-Man P, Chinnery PF. Leber Hereditary Optic Neuropathy. 2000 Oct 26 [updated 2021 Mar 11]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301353.
5. Pfeff er G, Burke A, Yu-Wai-Man P, Compston DA, Chinnery PF. Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations. Neurology. 2013;81(24):2073–81. doi: 10.1212/01.wnl.0000437308.22603.43. Epub 2013 Nov 6. PMID: 24198293; PMCID: PMC3863351.
6. Palace J. Multiple sclerosis associated with Leber’s Hereditary Optic Neuropathy. J Neurol Sci. 2009;286(1-2):24–7. doi: 10.1016/j.jns.2009.09.009. Epub 2009 Oct 1. PMID: 19800080.
7. Rościszewska-Żukowska I, Bartosik-Psujek H. Optic nerve atrophy and whole and regional brain atrophy in Leber’s hereditary optic neuropathy with multiple sclerosis-like disease with m.11778G > A mutation. Mult Scler Relat Disord. 2020;42:102071. doi: 10.1016/j.msard.2020.102071. Epub 2020 Apr 17. PMID: 32387972.
8. Kale N. Optic neuritis as an early sign of multiple sclerosis. Eye Brain. 2016;8:195–202. doi: 10.2147/EB.S54131. PMID: 28539814; PMCID: PMC5398757.
9. Dhanapalaratnam R, Markoulli M, Krishnan AV. Disorders of vision in multiple sclerosis. Clin Exp Optom. 2022;105(1):3–12. doi: 10.1080/08164622.2021.1947745. Epub 2021 Aug 4. PMID: 34348598.
10. Takai Y, Yamagami A, Ishikawa H. Leber’s hereditary optic neuropathy. Rinsho Shinkeigaku. 2024;64(5):326–332 (in Japanese). doi: 10.5692/clinicalneurol.cn-001924
11. Joshi S, Kermode AG. Harding’s disease: an important MS mimic. BMJ Case Rep. 2019;12(3):e228337. doi: 10.1136/bcr-2018-228337. PMID: 30936345; PMCID: PMC6453285.
12. Carelli V, La Morgia C, Yu-Wai-Man P. Mitochondrial optic neuropathies. Handb Clin Neurol. 2023;194:23–42. doi: 10.1016/B978-0-12-821751-1.00010-5 PMID: 36813316.
13. Piven V.D., Krasnov V.S., Novikova A.S., Piven F.M., Kushnir Ya.B., Totolian N.A. Neuromyelitis optica spectrum disorders: diagnosis and treatment, experiense of clinical observations. The Scientifi c Notes of the Pavlov University. 2018;25(3):7–13. (In Russ.). https://doi.org/10.24884/1607-4181-2018-25-3-7-13
14. Svetozarskiy SN, Kopishinskaya SV, Ruina EA, Antipenko EA. Clinical phenotypes of optic nerve damage in patients with neuromyelitis optica spectrum disorder. Russian Annals of Ophthalmology. 2023;139(2):61–67. (In Russ.). https://doi.org/10.17116/oftalma202313902161
15. Wingerchuk DM, Banwell B, Bennett JL, et al. International Consensus Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders. Neurology. 2015;85:177–89. doi: 10.1212/WNL.0000000000001729
16. Vanopdenbosch L., Dubois B., D’Hooghe M.B., Meire F., Carton H. Mitochondrial mutations of Leber’s hereditary optic neuropathy: a risk factor for multiple sclerosis. Journal of neurology. 2000;247(7):535–543. https://doi.org/10.1007/s004150070153
17. Rahimi G, Silverman M, Lucas M, Kazerooni L, Yousuf MM, Jafarpour S, Santoro JD. Leber’s hereditary optic neuropathy and multiple sclerosis: overlap between mitochondrial disease and neuroinfl ammation. Front Neurol. 2025;16:1538358. doi: 10.3389/fneur.2025.1538358. PMID: 40040912; PMCID: PMC11876024.
18. Bargiela D, Chinnery PF. Mitochondria in neuroinfl ammation — Multiple sclerosis (MS), leber hereditary optic neuropathy (LHON) and LHON-MS. Neurosci Lett. 2019;710:132932. doi: 10.1016/j.neulet.2017.06.051. Epub 2017 Jun 28. PMID: 28668384.
19. Chow-Wing-Bom HT, Callaghan MF, Wang J, Wei S, Dick F, Yu-Wai-Man P, Dekker TM. Neuroimaging in Leber Hereditary Optic Neuropathy: State-of-the-art and future prospects. Neuroimage Clin. 2022;36:103240. doi: 10.1016/j.nicl.2022.103240
20. Matthews L, Enzinger C, Fazekas F, Rovira A, Ciccarelli O, Dotti MT, Filippi M, Frederiksen JL, Giorgio A, Küker W, Lukas C, Rocca MA, De Stefano N, Toosy A, Yousry T, Palace J; MAGNIMS Network. MRI in Leber’s hereditary optic neuropathy: the relationship to multiple sclerosis. J Neurol Neurosurg Psychiatry. 2015;86(5):537–42. doi: 10.1136/jnnp-2014-308186
21. Kovács GG, Höftberger R, Majtényi K, Horváth R, Barsi P, Komoly S, Lassmann H, Budka H, Jakab G. Neuropathology of white matter disease in Leber’s hereditary optic neuropathy. Brain. 2005;128(Pt 1):35–41. doi: 10.1093/brain/awh310 Epub 2004 Oct 13. PMID: 15483043.
22. Wang L, Ding H, Chen BT, Fan K, Tian Q, Long M, Liang M, Shi D, Yu C, Qin W. Occult primary white matter impairment in Leber hereditary optic neuropathy. Eur J Neurol. 2021;28(9):2871–2881. doi: 10.1111/ene.14995 Epub 2021 Jul 9. PMID: 34166558.
23. Long M, Wang L, Tian Q, Ding H, Qin W, Shi D, Yu C. Brain white matter changes in asymptomatic carriers of Leber’s hereditary optic neuropathy. J Neurol. 2019;266(6):1474–1480. doi: 10.1007/s00415-019-09284-2 Epub 2019 Mar 25. PMID: 30911824.
24. Alorainy J, Alorfi Y, Karanjia R, Badeeb N. A Comprehensive Review of Leber Hereditary Optic Neuropathy and Its Association with Multiple Sclerosis-Like Phenotypes Known as Harding’s Disease. Eye Brain. 2024;16:17–24. doi: 10.2147/EB.S470184 PMID: 39100385; PMCID: PMC11296356.
25. Holmøy T., Beiske A.G., Zarnovicky S., Myro A.Z., Røsjø E., Kerty E. Severe infl ammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber’s optic neuropathy and multiple sclerosis — a case report. BMC neurology. 2016;16(1):197. https://doi.org/10.1186/s12883-016-0720-2
Review
For citations:
Prokhorov D.E., Nabiev Sh.R., Zhetishev R.R., Zhetisheva I.S., Voskresenskaya O.N. Combination of Leber’s Hereditary Optic Neuropathy and Multiple Sclerosis. Russian neurological journal. 2025;30(4):38-43. (In Russ.) https://doi.org/10.30629/2658-7947-2025-30-4-38-43